RNU6-464P

Across TCGA pan-cancer cohorts, RNU6-464P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU6-464P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-464P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-464P expression acts as an unfavorable survival marker.

STAD, BLCA, and COAD are the cancer types where RNU6-464P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.469	0.674	.002	111	view →
BLCA	DFS	Tertile	All	0.128	0.627	<.001	54	view →
COAD	OS	Tertile	II,III,IV	0.140	0.788	.002	54	view →
ESCA	OS	Tertile	All	0.195	0.872	<.001	36	view →
KIRC	DFS	Tertile	All	0.183	0.627	.019	30	view →
LAML	DFS	Tertile	All	0.112	0.582	.010	18	view →
OV	OS	Tertile	IV	0.249	0.632	.044	18	view →
LGG	DFS	Tertile	All	0.253	0.731	.003	18	view →
SKCM	DFS	Tertile	All	0.284	0.759	.008	15	view →
BRCA	DFS	Tertile	All	0.181	0.527	.009	12	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU6-464P–STAD (DFS)

Open the STAD breakdown →